Knott David M Jr

Knott David M Jr reported 86 holdings worth US$189M as of Jun 30, 2026 (Form 13F)

As of Jun 30, 2026 · Filed Aug 12, 2026

Knott David M Jr reported 86 holdings worth US$189M as of Jun 30, 2026. Largest: Alphabet Inc (google) Class C, Apollo Global Management, Inc. (new) and Syndax Pharmaceuticals, Inc. Filed Aug 12, 2026 (Form 13F).

Holdings
86
Value as reported
US$189M

The filing in full

CompanySharesValue as reported% of portfolio
Alphabet Inc (google) Class C90,687US$32.4M17.1%
Apollo Global Management, Inc. (new)225KUS$26.6M14.1%
Syndax Pharmaceuticals, Inc.437KUS$9.56M5.1%
Xeris Biopharma Holdings, Inc.1.06MUS$8.4M4.4%
Travere Therapeutics, Inc.147KUS$8.37M4.4%
Protagonist Therapeutics, Inc.63,000US$7.72M4.1%
Bridgebio Pharma, Inc.92,850US$6.92M3.7%
Iovance Biotherapeutics, Inc.1.6MUS$6.66M3.5%
Jp Morgan Chase & Co.18,098US$5.92M3.1%
Cogent Biosciences, Inc.111KUS$4.3M2.3%
Tg Therapeutics, Inc.66,839US$3.67M1.9%
Catalyst Bancorp, Inc.114KUS$3.58M1.9%
Agios Pharmaceuticals, Inc.95,058US$3.53M1.9%
Viridian Therapeutics, Inc.181KUS$3.32M1.8%
Relmada Therapeutics, Inc.451KUS$3.12M1.6%
Arcus Biosciences, Inc.81,241US$2.5M1.3%
Cybin, Inc.370KUS$2.45M1.3%
Rezolute, Inc.370KUS$1.92M1.0%
Alliancebernstein Holding L.p.48,000US$1.69M0.89%
Madrigal Pharmaceuticals, Inc.3,000US$1.61M0.85%
Atricure, Inc.51,400US$1.44M0.76%
Docgo Inc.2.67MUS$1.38M0.73%
Ardelyx, Inc.263KUS$1.34M0.71%
Ultragenyx Pharmaceutical Inc.38,069US$1.27M0.67%
Cullinan Therapeutics, Inc.69,182US$1.26M0.67%
Johnson & Johnson4,922US$1.25M0.66%
Vera Therapeutics, Inc.26,000US$1.12M0.59%
Orchestra Biomed Holdings, Inc.254KUS$1.09M0.58%
Spruce Biosciences, Inc.20,000US$1.08M0.57%
Connect Biopharma Holdings Limited445KUS$1.06M0.56%
Biogen Inc.4,000US$864K0.46%
Pfizer, Inc.32,337US$779K0.41%
Apple Inc2,494US$722K0.38%
Canadian Natural Resources Limited16,800US$664K0.35%
Pelthos Therapeutics Inc.22,073US$624K0.33%
International Business Machines Corporation2,142US$602K0.32%
Microsoft Corp.1,600US$597K0.32%
Verastem, Inc.155KUS$592K0.31%
Kura Oncology, Inc.52,767US$579K0.31%
Solid Biosciences Inc.56,208US$562K0.30%
Insmed Incorporated4,253US$453K0.24%
Lb Pharmaceuticals Inc12,965US$421K0.22%
Caredx, Inc.13,630US$388K0.21%
Q32 Bio Inc.30,412US$387K0.20%
Enliven Therapeutics, Inc.6,183US$314K0.17%
Ryman Hospitality Properties, Inc. (reit)2,400US$309K0.16%
Broadcom Inc.710US$268K0.14%
Kimberly-clark Corporation2,400US$263K0.14%
Nvidia Corporation1,280US$256K0.14%
Boston Scientific Corporation6,000US$256K0.14%
Rain Enhancement Technologies Holdco, Inc.102KUS$210K0.11%
Mondelez International, Inc.3,000US$174K0.09%
Quanta Services, Inc.176US$127K0.07%
Bristol-myers Squibb Company2,000US$115K0.06%
Eastern Bankshares, Inc.5,000US$111K0.06%
Legacy Housing Corporation4,000US$105K0.06%
Corteva, Inc.1,206US$102K0.05%
United Rentals, Inc.78US$88,3650.05%
Invivyd, Inc.100KUS$87,2400.05%
Amazon.com, Inc.300US$71,5020.04%
Danaher Corporation180US$34,2860.02%
Dow Inc.1,206US$32,9960.02%
Fs Kkr Capital Corp.2,875US$30,1870.02%
Blackstone Inc.210US$24,7110.01%
Unitedhealth Group Incorporated57US$23,6910.01%
Occidental Petroleum Corporation469US$22,7790.01%
Thermo Fisher Scientific Inc45US$22,5610.01%
Salesforce, Inc.77US$12,063<0.01%
Starwood Property Trust Inc.400US$6,552<0.01%
Kyndryl Holdings, Inc.428US$4,841<0.01%
Ge Healthcare Technologies Inc.50US$3,200<0.01%
Westinghouse Air Brake Technologies Corporation6US$1,618<0.01%
Evolus, Inc. Common Stock0US$00.00%
Jasper Therapeutics, Inc.0US$00.00%
Lenz Therapeutics, Inc.0US$00.00%
Adma Biologics Inc0US$00.00%
Catalyst Pharmaceuticals, Inc.0US$00.00%
Cytokinetics, Incorporated0US$00.00%
Dupont De Nemours, Inc.0US$00.00%

Source

View original at SEC

Related